IRulya Therapeutics (IRLA) Return on Invested Capital [ROIC] (2024 - 2025)
IRulya Therapeutics' Return on Invested Capital [ROIC] came in at -13034.34% for Q4 2025, down 12907.01 percentage points from -127.33% a year earlier and down 12819.87 percentage points from the prior quarter.
Powered by 
Analysis
IRulya Therapeutics (IRLA) Return on Invested Capital [ROIC] (2024 - 2025) Analysis & Trends
For FY2025, IRulya Therapeutics' Return on Invested Capital [ROIC] was -932.22%, down 843.17 percentage points from FY2024.
- Going back by year, Return on Invested Capital [ROIC] was -89.05% in FY2024 (-54.49 pp) and -34.56% in FY2023.
- The Q4 2025 figure represents the lowest quarterly Return on Invested Capital [ROIC] in data going back to Q1 2024.
- Year-over-year, Return on Invested Capital [ROIC] has declined for four consecutive quarters, with an average year-over-year change of -3312.11 percentage points over the last four quarters.
- Business Quant data shows IRLA's Return on Invested Capital [ROIC] at -214.47% (Q3 2025), -137.95% (Q2 2025) and -190.41% (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 38.16% |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 17.57% |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 24.28% |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 2.88% |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 24.11% |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 15.60% |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | -6.11% |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 12.34% |
| 10 | IRulya Therapeutics | 207.35 Mn | 91.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -13,034.34% |
| Sep 30, 2025 | -214.47% |
| Jun 30, 2025 | -137.95% |
| Mar 31, 2025 | -155.59% |
| Dec 31, 2024 | -109.85% |
| Sep 30, 2024 | -91.51% |
| Jun 30, 2024 | -74.65% |
| Mar 31, 2024 | -35.25% |
API Access
IRulya Therapeutics Return on Invested Capital [ROIC] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=IRLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-invested-capital-[roic]", "ticker": "IRLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=IRLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();